---
document_datetime: 2024-01-17 12:04:20
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/clopidogrel-acetylsalicylic-acid-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: clopidogrel-acetylsalicylic-acid-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 6.1852292
conversion_datetime: 2025-12-28 14:06:25.761954
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

## Clopidogrel/Acetylsalicylic acid Viatris

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                    | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ² / amended on   | Product Information affected3   | Summary   |
|----------------------|------------------------------------------------------------------------------------------|-------------------------------------|--------------------------------------------|---------------------------------|-----------|
| IG/1688              | A.2.a - Administrative change - Change in the (invented)nameofthemedicinalproductforCAPs | 15/01/2024                          |                                            | SmPC, Labelling and PL          |           |
| IB/0009/G            | This was an application for a group of variations.                                       | 08/09/2023                          | 22/09/2023                                 | SmPC and PL                     |           |

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

|         | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessmentof thesamechange for thereference product -Implementation of change(s) for which No newadditionaldataisrequiredtobesubmittedby theMAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessmentof thesamechangeforthereference product -Implementation of change(s) for which No newadditionaldata isrequiredtobesubmittedby the MAH C.I.2.a-Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product -Implementation of change(s) for which No new additional data is required to be submitted by the MAH   |            |            |             |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|
| IB/0007 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of thesame change for thereference product - Implementation of change(s) for which NO newadditionaldataisrequiredtobesubmittedby theMAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 02/08/2022 | 28/07/2023 | SmPC and PL |
| IB/0008 | B.I.d.1.a.4-Stability ofAS-Changein there-test period/storageperiod-Extensionorintroductionof a re-test period/storage period supported by real time data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 28/07/2022 | n/a        |             |

<div style=\"page-break-after: always\"></div>

| IAIN/0006/G   | This was an application for a group of variations. B.III.1.a.2-Submission of a new/updatedor deletionofPh.Eur.CertificateofSuitabilitytothe relevant Ph. Eur. Monograph - Updated certificate from an already approvedmanufacturer B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the   | 15/11/2021   | n/a        |                        | relevant Ph.Eur.Monograph-New certificate from an already approved manufacturer   |
|---------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-----------------------------------------------------------------------------------|
|               | TransferofMarketingAuthorisation                                                                                                                                                                                                                                                                                                         | 12/08/2021   | 19/10/2021 | SmPC, Labelling and PL | T/0005                                                                            |
|               | C.I.2.a -Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessmentofthesamechangefor thereference product -Implementation of change(s) for which No new additional data is required to be submitted by the MAH                                                                                     | 11/01/2021   | 25/02/2021 | SmPC and PL            | IB/0004                                                                           |
|               | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test                                                                                                                                                                                                                                       | 31/07/2020   | n/a        |                        | IA/0003 procedure                                                                 |
|               | B.II.f.1.z-Stability ofFp-Change in the shelf-life or storageconditionsofthefinishedproduct-Other variation                                                                                                                                                                                                                              | 03/03/2020   | 25/02/2021 | SmPC                   | IB/0001                                                                           |
|               | C.I.3.a - Change(s) in the SPC, Labelling or PL intendedtoimplementtheoutcomeofaprocedure                                                                                                                                                                                                                                                | 28/02/2020   | 25/02/2021 | SmPC and PL            | IAIN/0002                                                                         |

<div style=\"page-break-after: always\"></div>

| concerming PSURor PASS or the outcome of the assessment done under A 45/46-Implementation of wording agreed by the competent authority   |
|------------------------------------------------------------------------------------------------------------------------------------------|